Concepedia

Author

Michael Doubek

University Hospital BrnoORCID

Also Known As

Doubek Michael, Doubek, Michael, Frantisek Folber, M Doubek, M. Doubek, M., Doubek, MICHAEL DOUBEK, Michael Doubek, Michal Doubek, Stephen Mulligan

813

Publications

7.4K

Citations

44

H-Index

101

Concepts

All Affiliations

University Hospital BrnoMasaryk UniversityCentral European Institute of Technology – Masaryk UniversityCentral European Institute of TechnologyIstituti di Ricovero e Cura a Carattere Scientifico
MD

About

Michael Doubek is an author at University Hospital Brno specializing in medicine, hematology, and pathology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

25

47

2.5K

2

Health Sciences

9

9

793

3

Public Health

4

4

230

4

Engineering

1

1

68

5

Nursing

1

1

14

Michael Doubek

×

114

Publications

6.6K

Citations

43

H-Index

YearCitations

Chlorambucil plus ofatumumab versus chlorambucil alone in previously untreated patients with chronic lymphocytic leukaemia (COMPLEMENT 1): a randomised, multicentre, open-label phase 3 trial

Peter Hillmen, Tadeusz Robak, Ann Janssens,

The Lancet

2015

337

Germline mutations in ETV6 are associated with thrombocytopenia, red cell macrocytosis and predisposition to lymphoblastic leukemia

Leila Noetzli, Richard Lo, Alisa B. Lee‐Sherick,

Nature Genetics

2015

322

COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus

Lydia Scarfò, Thomas Chatzikonstantinou, Gian Matteo Rigolin,

Leukemia

2020

271

A complementary role of multiparameter flow cytometry and high-throughput sequencing for minimal residual disease detection in chronic lymphocytic leukemia: an European Research Initiative on CLL study

Andy C. Rawstron, Claudia Fazi, Andreas Agathangelidis,

Leukemia

2015

235

Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia

Robert J. Kreitman, Claire Dearden, Pier Luigi Zinzani,

Leukemia

2018

233

Cytogenetic complexity in chronic lymphocytic leukemia: definitions, associations, and clinical impact

Panagiotis Baliakas, Sabine Jeromin, Michalis Iskas,

Blood

2019

229

International reference analysis of outcomes in adults with B-precursor Ph-negative relapsed/refractory acute lymphoblastic leukemia

Nicola Gökbuget, Hervé Dombret, Josep‐María Ribera,

Haematologica

2016

205

Reproducible diagnosis of chronic lymphocytic leukemia by flow cytometry: An European Research Initiative on CLL (ERIC) & European Society for Clinical Cell Analysis (ESCCA) Harmonisation project

Andy C. Rawstron, Karl‐Anton Kreuzer, Asha Soosapilla,

Cytometry Part B Clinical Cytometry

2017

192

Monoallelic and biallelic inactivation of TP53 gene in chronic lymphocytic leukemia: selection, impact on survival, and response to DNA damage

Jitka Malčíková, Jana Šmardová, Ludmila Ročňová,

Blood

2009

184

Position of nonmuscle myosin heavy chain IIA (NMMHC-IIA) mutations predicts the natural history ofMYH9-related disease

Alessandro Pecci, Emanuele Panza, Núria Pujol‐Moix,

Human Mutation

2007

182

Page 1